+1-518-618-1030 866 - 552 - 3453 USA-Canada Toll Free
Published Date: 2017-07-27Number of Pages: 139

Albumin Market (Type - Human Serum Albumin, Bovine Serum Albumin, and Recombinant Albumin; Application - Blood Volumizer, Drug Formulation and Vaccines, and Life Sciences) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2025

Global Albumin Market: Snapshot

Prominent companies operating in the global albumin market are focusing on product and service extensions to grow their shares. This is serving to stoke competition in the market. In the near future, the competition is slated to intensify further on account of the savvy players striking partnerships or acquiring distributors to augment sales and expand businesses, globally.

At the forefront of driving growth in the global albumin market is the enhanced stability of products such as vaccines containing albumin as an excipient. Apart from this, the enhancement in molecular separation and protein purification technologies, coupled with rising use of recombinant albumin, is expected to fuel the global albumin market significantly over the forecast period.

On the flipside, however, strict rules pertaining to the use of albumin, their expensiveness, and concerns about their impact on human health are posing a roadblock to the market.

A report by Transparency Market Research predicts the global human albumin market to become worth US$10.359 bn by 2025 from US$4.8 bn in 2016 by clocking a CAGR of 9.2% from 2017 to 2025.

albumin market

Demand for Blood Volumizer from Emerging Economies Makes Blood Human Serum Albumin Leading Segment

Based on the types of product, the global albumin market can be classified into bovine serum albumin (BSA) extracted from fetal bovine serum, human serum albumin (HSA ) which is extracted from human plasma, and recombinant albumin produced from recombinant yeast, rice and other culture sources. Among them, the human serum albumin segment holds maximum share and going forward is expected to rise at a robust CAGR of 9.2% from 2017 to 2025. This is because, human serum albumin finds widespread application as a blood volumizer in case of burns, shocks, and other rare diseases. Demand for blood volumizer from emerging markets like China, India, and Brazil is expected to fuel this growth over the forecast period.

The recombinant albumin segment is projected to expand at a CAGR of 6.0% from 2017 to 2025. It finds widespread application in drug formulation, drug delivery, diagnostics, and in many of the life sciences procedures. Bovine serum albumin market is expected to grow at CAGR of 2.6% during forecast period. It mainly finds application as a major component of cell and microbial culture media. High demand of recombinant albumin and bovine serum albumin as an excipient in drug delivery and vaccine production is expected to drive demand for these segments in the foreseeable future.

China and India Majorly Fuelling Growth in Asia Pacific Market

Geographically, the key segments of the global albumin market are North America, Europe, Asia Pacific, Latin America and the Middle East and Africa. Asia Pacific, of them, dominates the market with a leading share and going forward is expected rise at a robust 11.5% CAGR, powered primarily by the emerging markets in India and China. A large pool of elderly and rising instances of rare diseases, burns and surgeries are said to be catalyzing growth in the region.

In the years ahead, however, North America and Europe are projected to lose their market share because of the rise in preference for albumin alternatives and ambiguity in use of albumin as proven blood volumizer.

Some of the key players operating in the global albumin market are Medxbio Pte. Ltd.CSL Behring LLC, Grifols International, S.A., Octapharma AG, Kedrion S.p.A., Baxalta Inc., Octapharma AG, InVitria, Kedrion S.p.A., Mitsubishi Tanabe Pharma Corporation, Albumedix A/S, Sigma-Aldrich Co. LLC. (Merck KGaA), Thermo Fisher Scientific, Inc., and HiMedia Laboratories Pvt. Ltd.

1. Preface
     1.1. Market Definition and Scope
     1.2. Market Segmentation
     1.3. Key Research Objectives
     1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Albumin Market

4. Market Overview
     4.1. Introduction
          4.1.1. Product Definition
          4.1.2. Industry Evolution / Developments
     4.2. Market Overview
     4.3. Key Market Indicators
     4.4. Market Dynamics
          4.4.1. Drivers
          4.4.2. Restraints
          4.4.3. Opportunities
          4.4.4. Trends
     4.5. Albumin Market Analysis and Forecast, 2016 – 2024
          4.5.1. Market Revenue Projections (US$ Mn)
     4.6. Albumin Market  - Global Supply Demand Scenario
     4.7. Market Outlook
     4.8. Porter’s five forces analysis

5. Global Albumin Market Analysis and Forecasts, By Product Type
     5.1. Introduction & Definition
     5.2. Key Findings / Developments
     5.3. Key Trends
     5.4. Market Value (US$ Mn) Forecast By Product Type
          5.4.1. Human Serum Albumin
          5.4.2. Bovine Serum Albumin
          5.4.3. Recombinant Albumin
     5.5. Comparison Matrix
     5.6. Market Attractiveness By Product Type

6. Global Albumin Market Analysis and Forecasts, By Application
     6.1. Introduction & Definition
     6.2. Key Findings / Developments
     6.3. Key Trends
     6.4. Market Value (US$ Mn) Forecast By Application
          6.4.1. Blood Volumizer
          6.4.2. Drug Formulation and Vaccines
          6.4.3. Life Sciences
          6.4.4. Others
     6.5. Comparison Matrix
     6.6. Market Attractiveness By Application

7. Global Albumin Market Analysis and Forecasts, By Region
     7.1. Key Findings
     7.2. Policies and Regulations
     7.3. Market Value (US$ Mn) Forecast By Region
          7.3.1. North America
          7.3.2. Europe
          7.3.3. Asia Pacific
          7.3.4. Rest of the World
     7.4. Market Attractiveness By Region

8. North America Albumin Market Analysis and Forecast
     8.1. Introduction
     8.2. Key Findings / Developments
     8.3. Key Trends
     8.4. Market Value (US$ Mn) Forecast By Product Type
          8.4.1. Human Serum Albumin
          8.4.2. Bovine Serum Albumin
          8.4.3. Recombinant Albumin
     8.5. Market Value (US$ Mn) Forecast By Application
          8.5.1. Blood Volumizer
          8.5.2. Drug Formulation and Vaccines
          8.5.3. Life Sciences
          8.5.4. Others
     8.6. Market Size (US$ Mn) Forecast, By Country
          8.6.1. U.S.
          8.6.2. Canada
     8.7. Market Attractiveness Analysis
          8.7.1. By Product Type
          8.7.2. By Application
          8.7.3. By Country

9. Europe Albumin Market Analysis and Forecast
     9.1. Introduction
     9.2. Key Findings / Developments
     9.3. Key Trends
     9.4. Market Value (US$ Mn) Forecast By Product Type
          9.4.1. Human Serum Albumin
          9.4.2. Bovine Serum Albumin
          9.4.3. Recombinant Albumin
     9.5. Market Value (US$ Mn) Forecast By Application
          9.5.1. Blood Volumizer
          9.5.2. Drug Formulation and Vaccines
          9.5.3. Life Sciences
          9.5.4. Others
     9.6. Market Size (US$ Mn) Forecast, By Country
          9.6.1. Germany
          9.6.2. U.K.
          9.6.3. France
          9.6.4. Spain
          9.6.5. Italy
          9.6.6. Rest of Europe
     9.7. Market Attractiveness Analysis
          9.7.1. By Product Type
          9.7.2. By Application
          9.7.3. By Country

10. Asia Pacific Albumin Market Analysis and Forecast
     10.1. Introduction
     10.2. Key Findings / Developments
     10.3. Key Trends
     10.4. Market Value (US$ Mn) Forecast By Product Type
          10.4.1. Human Serum Albumin
          10.4.2. Bovine Serum Albumin
          10.4.3. Recombinant Albumin
     10.5. Market Value (US$ Mn) Forecast By Application
          10.5.1. Blood Volumizer
          10.5.2. Drug Formulation and Vaccines
          10.5.3. Life Sciences
          10.5.4. Others
     10.6. Market Size (US$ Mn) Forecast, By Country
          10.6.1. Japan
          10.6.2. China
          10.6.3. India
          10.6.4. Australia & New Zealand
          10.6.5. Rest of Asia Pacific
     10.7. Market Attractiveness Analysis
          10.7.1. By Product Type
          10.7.2. By Application
          10.7.3. By Country

11. Rest of the World Albumin Market  Analysis and Forecast
     11.1. Introduction
     11.2. Key Findings / Developments
     11.3. Key Trends
     11.4. Market Value (US$ Mn) Forecast By Product Type
          11.4.1. Human Serum Albumin
          11.4.2. Bovine Serum Albumin
          11.4.3. Recombinant Albumin
     11.5. Market Value (US$ Mn) Forecast By Application
          11.5.1. Blood Volumizer
          11.5.2. Drug Formulation and Vaccines
          11.5.3. Life Sciences
          11.5.4. Others
     11.6. Market Attractiveness Analysis
          11.6.1. By Product Type
          11.6.2. By Application

12. Competition Landscape
     12.1. Market Player – Competition Matrix (By Tier and Size of companies)
     12.2. Company Profiles (Details – Overview, Financials, Recent Developments, Strategy)
          12.2.1. CSL Behring LLC
                 12.2.1.1. Company Overview (HQ, Business Segments, Employee Strength)
                 12.2.1.2. Product Portfolio
                 12.2.1.3. SWOT Analysis
                 12.2.1.4. Financial Overview
                 12.2.1.5. Strategic Overview
          12.2.2. GRIFOLS INTERNATIONAL, S.A.
                 12.2.2.1. Company Overview (HQ, Business Segments, Employee Strength)
                 12.2.2.2. Product Portfolio
                 12.2.2.3. SWOT Analysis
                 12.2.2.4. Financial Overview
                 12.2.2.5. Strategic Overview
          12.2.3. Shire Plc. (Baxalta Inc.)
                 12.2.3.1. Company Overview (HQ, Business Segments, Employee Strength)
                 12.2.3.2. Product Portfolio
                 12.2.3.3. SWOT Analysis
                 12.2.3.4. Financial Overview
                 12.2.3.5. Strategic Overview
          12.2.4. Octapharma AG
                 12.2.4.1. Company Overview (HQ, Business Segments, Employee Strength)
                 12.2.4.2. Product Portfolio
                 12.2.4.3. SWOT Analysis
                 12.2.4.4. Financial Overview
                 12.2.4.5. Strategic Overview
          12.2.5. InVitria
                 12.2.5.1. Company Overview (HQ, Business Segments, Employee Strength)
                 12.2.5.2. Product Portfolio
                 12.2.5.3. SWOT Analysis
                 12.2.5.4. Financial Overview
                 12.2.5.5. Strategic Overview
          12.2.6. Kedrion S.p.A
                 12.2.6.1. Company Overview (HQ, Business Segments, Employee Strength)
                 12.2.6.2. Product Portfolio
                 12.2.6.3. SWOT Analysis
                 12.2.6.4. Financial Overview
                 12.2.6.5. Strategic Overview
          12.2.7. HiMedia Laboratories
                 12.2.7.1. Company Overview (HQ, Business Segments, Employee Strength)
                 12.2.7.2. Product Portfolio
                 12.2.7.3. SWOT Analysis
                 12.2.7.4. Financial Overview
                 12.2.7.5. Strategic Overview
          12.2.8. Medxbio Pte Ltd
                 12.2.8.1. Company Overview (HQ, Business Segments, Employee Strength)
                 12.2.8.2. Product Portfolio
                 12.2.8.3. SWOT Analysis
                 12.2.8.4. Financial Overview
                 12.2.8.5. Strategic Overview
          12.2.9. Mitsubishi Tanabe Pharma Corporation
                 12.2.9.1. Company Overview (HQ, Business Segments, Employee Strength)
                 12.2.9.2. Product Portfolio
                 12.2.9.3. SWOT Analysis
                 12.2.9.4. Financial Overview
                 12.2.9.5. Strategic Overview
          12.2.10. Albumedix A/S
                   12.2.10.1. Company Overview (HQ, Business Segments, Employee Strength)
                   12.2.10.2. Product Portfolio
                   12.2.10.3. SWOT Analysis
                   12.2.10.4. Financial Overview
                   12.2.10.5. Strategic Overview
          12.2.11. Sigma-Aldrich Co. LLC.
                 12.2.11.1. Company Overview (HQ, Business Segments, Employee Strength)
                 12.2.11.2. Product Portfolio
                 12.2.11.3. SWOT Analysis
                 12.2.11.4. Financial Overview
                 12.2.11.5. Strategic Overview
          12.2.12. Thermo Fisher Scientific Inc.
                 12.2.12.1. Company Overview (HQ, Business Segments, Employee Strength)
                 12.2.12.2. Product Portfolio
                 12.2.12.3. SWOT Analysis
                 12.2.12.4. Financial Overview
                 12.2.12.5. Strategic Overview

13. Key Take Away

List of Figures

Figure 01: Global Albumin Market Size, by Product Type (US$ Mn), 2016
Figure 02: Global Albumin Market Share, by Application (% Share), 2016
Figure 03: Albumin market Top trends and drivers
Figure 04: Market Share analysis, by Region
Figure 05: Major drivers of albumin market, by Region
Figure 06: Market Opportunity Map
Figure 07: Key Industry Events
Figure 08: Global Albumin Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2025
Figure 09: Market Value Share, by Product Type (2016)
Figure 10: Market Value Share, by Application (2016)
Figure 11: Market Value Share, by Region (2016)
Figure 12: Porter’s Analysis, Albumin Market
Figure 13: Global Albumin Market Value Share Analysis, by Product Type, 2016 and 2025
Figure 14: Global Human Serum Albumin Market Revenue (US$ Mn), 2015–2025
Figure 15: Global Bovine Serum Albumin Market Revenue (US$ Mn), 2015–2025
Figure 16: Global Recombinant Albumin Market Revenue (US$ Mn), 2015–2025
Figure 17: Global Albumin Market Attractiveness Analysis, by Product Type
Figure 18: Global Albumin Market Value Share Analysis, by Application, 2016 and 2025
Figure 19: Global Albumin as Blood Volumizer Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2025
Figure 20: Global Albumin for Drug Formulation and Vaccines Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2025
Figure 21: Global Albumin for Life Sciences Market Revenue (US$ Mn), 2015–2025
Figure 22: Global Albumin for Other Application Market Revenue (US$ Mn), 2015–2025
Figure 23: Global Albumin Market Attractiveness Analysis, by Application
Figure 24: Global Albumin Market Snapshot, by Country 
Figure 25: Global Albumin Market Value Share Analysis, by Region, 2016 and 2025
Figure 26: Global Albumin Market Attractiveness Analysis, by Region
Figure 27: North America Albumin Market Size (US$ Mn) Forecast, 2017–2025
Figure 28: North America Market Attractiveness Analysis, by Country
Figure 29: North America Albumin Market Value Share Analysis, by Product Type, 2016 and 2025
Figure 30: North America Albumin Market Value Share Analysis, by Application, 2016 and 2025
Figure 31: North America Albumin Market Value Share Analysis, by Country, 2016 and 2025
Figure 32: North America Albumin Market Attractiveness Analysis, by Product
Figure 33: North America Albumin Market Attractiveness Analysis, by Application
Figure 34: Europe Albumin Market Size (US$ Mn) Forecast and Y-o-Y Growth Projection, 2017–2025
Figure 35: Europe Albumin Market Attractiveness Analysis, by Country
Figure 36: Europe Albumin Market Value Share Analysis, by Product, 2016 and 2025
Figure 37: Europe Albumin Market Value Share Analysis, by Application, 2016 and 2025
Figure 38: Europe Albumin Market Value Share Analysis, by Country, 2016 and 2025
Figure 39: Europe Albumin Market Attractiveness Analysis, by Product 
Figure 40: Europe Albumin Market Attractiveness Analysis, by Application
Figure 41: Asia Pacific Albumin Market Size (US$ Mn) Forecast, 2017–2025
Figure 42: Asia Pacific Market Attractiveness Analysis, by Country
Figure 43: Asia Pacific Albumin Market Value Share Analysis, by Product Type, 2016 and 2025
Figure 44: Asia Pacific Albumin Market Value Share Analysis, by Application, 2016 and 2025
Figure 45: Asia Pacific Albumin Market Value Share Analysis, by Country, 2016 and 2025
Figure 46: Asia Pacific Albumin Market Attractiveness Analysis, by Product 
Figure 47: Asia Pacific Albumin Market Attractiveness Analysis, by Application
Figure 48: Rest of the World Albumin Market Size (US$ Mn) Forecast, 2017–2025
Figure 49: Rest of the World Albumin Market Value Share Analysis, by Product Type, 2016 and 2025
Figure 50: Rest of the World Albumin Market Value Share Analysis, by Application, 2016 and 2025
Figure 51: Rest of the World Albumin Market Attractiveness Analysis, by Product 
Figure 52: Rest of the World Albumin Market Attractiveness Analysis, by Application
Figure 53: Breakdown of CSL Behring LLC Net Sales (%Share) , by Region (2016)
Figure 54: CSL Behring LLC Revenue (US$ Mn) and Y-o-Y Growth (%), 2013–2016
Figure 55: Breakdown of Grifols International, S.A. Net Sales (%share), by Region (2016)
Figure 56: Grifols International, S.A. Revenue (US$ Mn) and Y-o-Y Growth (%), 2013–2016
Figure 57: Breakdown of Baxalta, Inc. Net Sales, by Segment, 2015 Revenue (% share) 
Figure 58: Baxalta, Inc. Revenue (US$ Mn) and Y-o-Y Growth (%), 2012–2015 (Shire plc)
Figure 59: Octapharma AG Revenue (US$ Mn) and Y-o-Y Growth (%), 2013–2016
Figure 60: Breakdown of Kedrion S.p.A. Net Sales (% Share), by Region (2016)
Figure 61: Kedrion S.p.A.  Revenue (US$ Mn) and Y-o-Y Growth (%), 2013–2016
Figure 62: Breakdown of Mitsubishi Tanabe Pharma Corporation Net Sales (% Share), by Region (2015)
Figure 63: Mitsubishi Tanabe Pharma Corporation Revenue (US$ Mn) and Y-o-Y Growth (%), 2012–2015
Figure 64: Albumedix A/S Breakdown of Net Sales (% Share), by Region (2016)
Figure 65: (Novozyme A/S) Revenue (US$ Mn) and Y-o-Y Growth (%), 2013–2016
Figure 66: Breakdown of Net Sales (% Share), by Business Segments (Merck KGaA) (2016)
Figure 67: Revenue (US$ Mn) and Y-o-Y Growth (%), 2013–2016 (Merck KGaA)
Figure 68: Breakdown of Thermo Fisher Scientific, Inc. Net Sales (% Share), by Business segments (2016)
Figure 69: Thermo Fisher Scientific, Inc. Revenue (US$ Mn) and Y-o-Y Growth (%), 2013–2016

List of Tables
 
Table 01: Global Albumin Market Value (US$ Mn) Forecast, by Product Type, 2015–2025
Table 02: Global Albumin Market Value (US$ Mn) Forecast, by Application, 2015–2025
Table 03: Global Albumin Market Size (US$ Mn) Forecast, by Region, 2015–2025
Table 04: North America Albumin Market Value (US$ Mn) Forecast, by Product Type, 2015–2025
Table 05: North America Albumin Market Value (US$ Mn) Forecast, by Application, 2015–2025
Table 06: North America Albumin Market Value (US$ Mn) Forecast, by Country, 2015–2025
Table 07: Europe Albumin Market Value (US$ Mn) Forecast, by Product, 2015–2025
Table 08: Europe Albumin Market Value (US$ Mn) Forecast, by Application, 2015–2025
Table 09: Europe Albumin Market Value (US$ Mn) Forecast, by Country, 2015–2025
Table 10: Asia Pacific Albumin Market Value (US$ Mn) Forecast, by Product Type, 2017–2025
Table 11: Asia Pacific Albumin Market Value (US$ Mn) Forecast, by Application, 2015–2025
Table 12: Asia Pacific Albumin Market Value (US$ Mn) Forecast, by Country, 2015–2025
Table 13: Rest of the World Albumin Market Value (US$ Mn) Forecast, by Product Type, 2015–2025
Table 14: Rest of the World Albumin Market Value (US$ Mn) Forecast, by Application, 2015–2025
 

Global Albumin Market: Overview

Albumin is a plasma protein produced in liver, it is a water soluble globular protein contributes 50% to 60% of blood plasma proteins. Albumin acts as a blood volume controlling factor, maintaining the oncotic pressure, beside which it also plays an important role in transport of certain ions, bile salts, hormones, etc. Albumin is derived from plasma fractionation process, commonly used serum albumins are human serum albumins and bovine serum albumins. With technological development, recombinant albumins are produced using recombinant techniques in rice plants, yeast species, and other cell lines. The array of albumin applications vary as per the type of albumin and its features. Recombinant albumin has found its application in areas such as excipients for drug delivery and production, reagent in life sciences procedures such as blotting, etc. Bovine serum albumin is widely used as a component of cell culture media and other procedures in life sciences.

Global Albumin Market: Drivers and Restraints

Human Serum albumin is widely used as blood volumizer to maintain the oncotic pressure and blood volume in chronic diseases, rare blood conditions, certain liver diseases, transfusion therapies, burns, shocks and other hypovolemic conditions. With increase in prevalence of rare diseases, incidences of shocks, trauma and other fatalities, demand for human serum albumin is projected to grow during the forecast period. High acceptance of albumin as an excipient in drug delivery and vaccines production is projected to drive albumin market contributed by rise in demand for biologics and vaccines. Scarcity of plasma for fractionation is a major concern among the industry players which is anticipated to hamper growth for albumin market. Moreover use of alternatives to albumin in replacement therapies, and other medical applications is expected to restrain the growth for albumin market.

Global Albumin Market: Segmentation

Global albumin market has been segmented based on type of albumin, application and geography. Based on product type, the market has been segmented into human serum albumin, bovine serum albumin and recombinant albumin. Among these human serum albumin segment is expected to dominate the market owing to high demand as blood volumizer in emerging markets. While recombinant albumin usage in life sciences and drug delivery and vaccines is projected to grow driving the growth for albumin market. Ethical issues over use bovine fetus for extracting bovine serum for albumin production, and concerns over contamination and impurities are anticipated to hamper growth for bovine serum albumin during forecast period from 2017 to 2025.

Based on application, global albumin market is segmented into blood volumizer, drug delivery & vaccines, life sciences and others. With rising prevalence’s of rare and chronic diseases coupled with growing numbers of surgeries and replacement therapies, consumption of human serum albumin as blood volumizer is expected to rise. Recombinant albumin and bovine serum albumin usage in drug delivery and vaccines production is projected to grow with increasing demand for biologics and vaccines. Albumin is also used in areas such as medical imaging, nuclear medicine and other area, the others application segment is estimated to have moderate growth during the forecasted period.

Based on geography, global albumin market is segmented into North America, Europe, Asia Pacific and rest of the World. Asia Pacific region contributed largest share in global albumin market and is projected to dominate during the forecast period from 2017 to 2025. High demand for human serum album in from emerging markets like China and India is projected to propel this growth. With well-established pharmaceutical and biotechnology industry in North America region demand for recombinant albumin in drug delivery & vaccines and life sciences is projected to grow. With presence of large players in Europe in plasma proteins industry the albumin market in Europe is projected to have prominent growth during the forecast period from 2017 to 2025.

Global Albumin Market: Competitive Analysis

The report also profiles major players in the market based on various attributes such as company overview, financial overview, SWOT analysis, key business strategies, product portfolio, and recent developments. Key companies profiled in the report include CSL Behring LLC, Grifols International, S.A., Octapharma AG, Sigma-Aldrich Co. LLC., HiMedia Laboratories Pvt. Ltd., InVitria, Thermo Fisher Scientific Inc., Mitsubishi Tanabe Pharma Corporation, and MedxBio Pte. Ltd.

The global albumin market has been segmented as follows:

Global Albumin Market, by Product Type

  • Human Serum Albumin
  • Bovine Serum Albumin
  • Recombinant Albumin

Global Albumin Market, by Application

  • Blood volumizer
  • Drug Formulation and Vaccines
  • Life Sciences
  • Others

Global Albumin Market, by Region

  • North America
  • Europe
  • Asia Pacific
  • Rest of the World


 
 
Back To Top